Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple doses of XPF-001 in healthy volunteers.

The effect of food on the pharmacokinetics of XPF-001 will also be studied.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00813670
Study type Interventional
Source Xenon Pharmaceuticals Inc.
Contact
Status Completed
Phase Phase 1
Start date November 2008
Completion date July 2009

See also
  Status Clinical Trial Phase
Completed NCT00765427 - Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers Phase 1
Completed NCT04339283 - Effect of Standardized Hibiscus Sabdariffa Tea in Seemingly Healthy Human Volunteers N/A
Completed NCT02219438 - Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses Phase 4